Standard care for CRSwNP consists of corticosteroids in the nose ... and 25% to 30% of them develop nasal polyps as a result. Sanofi and Regeneron have said that CRSwNP has been helping to ...

New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...

Learn more about whether Alvotech or Catalyst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Simultaneously, the three regulators are also reviewing a second potential indication for depemokimab as an add-on therapy for chronic rhinosinusitis with nasal polyps (CRSwNP). GSK has said ...

Asthma and Antibiotic Use May Predict Nasal Polyp Recurrence After Endoscopic ... is more effective than the current treatment of steroid tablets, reducing the need for further treatment by ...

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU) Approval based on Phase 3 trials demonstrating Dupixent ...

Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...

Post-nasal drip treatments include rinsing your sinuses, using steam, avoiding allergens, and addressing the underlying cause. If your post-nasal drip symptoms don't go away, you may need to see a ...

Corticosteroid nasal sprays – such as Flonase Allergy Relief (fluticasone propionate), Rhinocort Allergy (budesonide) and Nasacort Allergy 24 Hour (triamcinolon) — can help alleviate nasal ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...